O15 Recognition of subclinical macrophage activation syndrome in an adolescent systemic juvenile idiopathic arthritis patient receiving tocilizumab: a case report

CASE REPORT - INTRODUCTION: Macrophage Activation Syndrome (MAS) affects approximately 10% of patients with Systemic Juvenile Idiopathic Arthritis (sJIA) which left untreated can have fatal consequences. MAS in sJIA often occurs in the context of uncontrolled disease or following a concurrent infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Sue, Talbot, Jonathan, Clinch, Jacqui, Ohlsson, Vicky, Rogers, Valerie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Oral Abstract Presentations (Wednesday 14 October 2020)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607356/
http://dx.doi.org/10.1093/rap/rkaa054.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607356/
http://dx.doi.org/10.1093/rap/rkaa054.003

Ejemplares similares